HAEMONETICS CORP - Common Stock (HAE)

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / Common Stock
Shares outstanding
47,898,935
Total 13F shares
53,079,424
Share change
-1,350,731
Total reported value
$1,853,545,493
Price per share
$34.92
Number of holders
168
Value change
-$47,792,045
Number of buys
68
Number of sells
91

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2014

As of 30 Sep 2014 HAEMONETICS CORP - Common Stock (HAE) had 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 53,079,424 shares of stock of the company.
Largest 10 holders included Neuberger Berman Group LLC, VANGUARD GROUP INC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock Fund Advisors, FMR LLC, VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P., WELLINGTON MANAGEMENT CO LLP, Black Creek Investment Management Inc., Van Berkom & Associates Inc., and WESTWOOD HOLDINGS GROUP INC.
This table shows 168 institutional shareholders of the security as of 30 Sep 2014.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.